United Therapeutics Chairperson, CEO Martine A. Rothblatt reports disposal of common shares worth $4.4 million
Bitget2026/09/24 20:32- United Therapeutics Chairperson, CEO Martine A. Rothblatt reported option exercise, acquiring 9,500 common shares at USD 117.76.
- Family trust then sold 9,500 shares in multiple trades at weighted-average prices from USD 488.6962 to USD 500.05.
- Trust holdings in common stock fell to 324,443 shares following the transactions dated Sept. 23.
- Trust-held stock options increased to 375,910 following the exercise.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.
WikiLeaks Founder Julian Assange Welcomes Daughter With Terminator Quote
Crypto prices
More
